Related Experiment Videos
[Portazygos disconnection in the treatment of portal hypertension]
Insights
Surgical disconnection of the azygos vein effectively treats cirrhotic portal hypertension, with amplification Hassab
Area of Science:
- Hepatology
- Surgical Gastroenterology
- Vascular Surgery
Background:
- Portal hypertension in cirrhotic patients presents significant bleeding risks.
- Portazygos disconnection is a surgical approach to manage portal hypertension.
Purpose of the Study:
- To evaluate the efficacy and outcomes of various portazygos disconnection procedures.
- To compare different surgical techniques for treating cirrhotic portal hypertension.
Main Methods:
- A retrospective analysis of 116 patients with cirrhotic portal hypertension treated between January 1988 and February 1993.
- Procedures included Hassab's procedure, amplification Hassab's procedure, pericardial devascularization, and transthoracic portazygos disconnection.
Main Results:
- Operative mortality was 6.9%, with a 1-month hemorrhage rate of 8.6%.
- Recurrent hemorrhage occurred in 18.5% of patients during follow-up (14-75 months).
- One-year and three-year survival rates were 94.2% and 81.8%, respectively.
Conclusions:
- Amplification Hassab's procedure and transthoracic portazygos disconnection demonstrated favorable outcomes.
- These surgical interventions offer effective management for cirrhotic portal hypertension with acceptable survival rates.
Abstract:
Since January 1988 to February 1993, 116 cases of cirrhotic portal hypertension were treated with portazygos disconnection. 37 cases were treated with Hassab's procedure, 36 cases were treated with amplification Hassab's procedure, 33 cases were treated with pericardial devascularization with circular interruption of blood flow of fundus, 10 cases were treated with transthoracic portazygos disconnection. The operative mortality was 6.9%. The hemorrhage rate was 8.6% in one month after the operation. All of 108 patients discharged from the hospital were followed up for 14 months to 75 months. The recurrent hemorrhage rate was 18.5% in the period. The one-year and three-year survival rate after the operation were 94.2% and 81.8%, respectively. The results we have got indicate that amplification Hassab's procedure and transthoracic portazygos disconnection have good effect.